FDA
approval
· 2023-11-01
FDA Approved: VOQUEZNA — Original Application (Phathom Pharmaceuticals Inc.)
Summary
FDA approves Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals as an original application for the treatment of Helicobacter pylori infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VOQUEZNA (VONOPRAZAN FUMARATE)